Recent Publications Disruption of canonical AHR-mediated induction of hepatocyte PKM2 expression compromises antioxidant defenses and increases TCDD-induced hepatotoxicityNovember 3, 2024 2,3,7,8-Tetrachlorodibenzo-<em>p</em>-dioxin (TCDD) elicited dose-dependent shifts in the murine urinary metabolome associated with hepatic AHR-mediated differential gene expressionNovember 1, 2024 Cell-specific AHR-driven differential gene expression in the mouse liver cell following acute TCDD exposureAugust 28, 2024 Inhibition of the urea cycle by the environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin increases serum ammonia levels in miceNovember 28, 2023 Characterizing the impact of simvastatin co-treatment of cell specific TCDD-induced gene expression and systemic toxicityOctober 3, 2023 Generative modeling of single-cell gene expression for dose-dependent chemical perturbationsAugust 21, 2023 A Case for Accelerating Standards to Achieve the FAIR Principles of Environmental Health Research Experimental DataJune 23, 2023 Cystine/Glutamate Xc<sup>-</sup> Antiporter Induction Compensates for Transsulfuration Pathway Repression by 2,3,7,8-Tetrachlorodibenzo-<em>p</em>-dioxin (TCDD) to Ensure Cysteine for Hepatic Glutathione BiosynthesisMay 15, 2023 Consequences of reprogramming acetyl-CoA metabolism by 2,3,7,8-tetrachlorodibenzo-p-dioxin in the mouse liverMarch 14, 2023 A Physiologically Based Pharmacokinetic (PBPK) Modeling Framework for Mixtures of Dioxin-like CompoundsNovember 24, 2022 Single-cell transcriptomics shows dose-dependent disruption of hepatic zonation by TCDD in miceOctober 12, 2022 Dioxin-elicited decrease in cobalamin redirects propionyl-CoA metabolism to the β-oxidation-like pathway resulting in acrylyl-CoA conjugate buildupAugust 5, 2022 Genome-Wide ChIPseq Analysis of AhR, COUP-TF, and HNF4 Enrichment in TCDD-Treated Mouse LiverFebruary 15, 2022 Benchmarking of a Bayesian single cell RNAseq differential gene expression test for dose-response study designsJanuary 21, 2022 Aryl Hydrocarbon Receptor (AhR) Activation by 2,3,7,8-Tetrachlorodibenzo-<em>p</em>-Dioxin (TCDD) Dose-Dependently Shifts the Gut Microbiome Consistent with the Progression of Non-Alcoholic Fatty Liver DiseaseNovember 27, 2021 Click here to see more.